Real-world management strategies of anticoagulated atrial fibrillation patients following a clinically significant bleeding episode: Afib patients bleeding on …
P Brouillard, JB Masson, JM Raymond, M Riahi… - Canadian Journal of …, 2024 - Elsevier
Background Systemic anticoagulation for stroke prevention in patients with atrial fibrillation
(AF) carries inherent bleeding risks and determining whether and when to resume …
(AF) carries inherent bleeding risks and determining whether and when to resume …
Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
X Yan, B Wang, P Xia, C Lan, Q Wang… - Clinical and Applied …, 2023 - journals.sagepub.com
The efficacy and safety of anticoagulant therapy in patients with acute ischemic stroke (AIS)
and atrial fibrillation (AF) remain uncertain. This study enrolled 431 AIS and AF patients from …
and atrial fibrillation (AF) remain uncertain. This study enrolled 431 AIS and AF patients from …
Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Older Patients with Atrial Fibrillation: A Population-Based Cohort Study
Background There are no clinical trials with head-to-head comparison between the two most
commonly used oral anticoagulants (apixaban and rivaroxaban) in patients with atrial …
commonly used oral anticoagulants (apixaban and rivaroxaban) in patients with atrial …
Drug-related problems associated with direct oral anticoagulants: an observational cross-sectional study of medical record review by pharmacists in a large teaching …
MMY Chow, DJJ Chua, VSY Wong, SY How… - Research and Practice …, 2024 - Elsevier
Abstract Background Prescribing DOACs presents with challenges in the elderly and
patients with renal and hepatic impairment. To mitigate safety risks, pharmacists have a role …
patients with renal and hepatic impairment. To mitigate safety risks, pharmacists have a role …
The Association between Direct Oral Anticoagulants Prescribing Behavior and Non-Valvular Atrial Fibrillation Outcomes: An Instrumental Variable Analysis of Real …
N Atreja, SG Severtson, J Jiang, C Gao… - Journal of Clinical …, 2023 - mdpi.com
Several observational studies have compared apixaban with rivaroxaban in patients with
non-valvular atrial fibrillation (NVAF), but these analyses may be confounded by …
non-valvular atrial fibrillation (NVAF), but these analyses may be confounded by …
Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma
P Dasgupta, JF Rousseau - Journal of Neuro-Oncology, 2024 - Springer
Purpose Cancer is an independent risk factor for the development of venous
thromboembolism (VTE). However, patients with high-grade glioma (HGG) including …
thromboembolism (VTE). However, patients with high-grade glioma (HGG) including …
Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation and Liver Cirrhosis
Background Evidence of the pharmacodynamics of direct oral anticoagulants (DOACs) is
limited in patients with atrial fibrillation (AF) and liver cirrhosis (LC). This study aimed to …
limited in patients with atrial fibrillation (AF) and liver cirrhosis (LC). This study aimed to …
[HTML][HTML] Assessing the Safety and Efficacy of Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation: A Systemic Review and Meta-Analysis
GS Virk, S Javed, R Chaudhry, MM Moazam… - Cureus, 2024 - ncbi.nlm.nih.gov
An effective anticoagulation therapy is required for patients with atrial fibrillation because it
presents a significant risk of stroke. The current study evaluates the relative safety as well as …
presents a significant risk of stroke. The current study evaluates the relative safety as well as …
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution
M Cohen, AC Spyropoulos, SG Goodman… - … , Quality & Outcomes, 2024 - mcpiqojournal.org
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution - Mayo Clinic
Proceedings: Innovations, Quality & Outcomes Skip to Main Content Skip to Main Menu …
Proceedings: Innovations, Quality & Outcomes Skip to Main Content Skip to Main Menu …
In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation
Spontaneous intracerebral hemorrhage (ICH) constitutes 10–15% of all strokes, and is a
significant cause of mortality and morbidity. Survivors of ICH, especially those with atrial …
significant cause of mortality and morbidity. Survivors of ICH, especially those with atrial …